$39.65
-1.82-4.39%
$39.65
-1.82-4.39%
Benzinga
Benzinga
Benzinga
月曜日, 10 19
Benzinga
© 2026 Benzinga | All Rights Reserved
Spruce Biosciences (SPRB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-4.79 | $-7.32 | $-12.86 | $-15.56 |
| Actual | $-6.68 | $-8.94 | $-36.25 | $-14.58 |
| Surprise | -39.5% | -22.1% | -181.9% | +6.30% |
| Revenue | ||||
| Estimate | — | — | — | $200000 |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | -100.0% |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-6.68 | $-4.79 | -39.5 % |
| Q1 | May 13, 2026 | $-8.94 | $-7.32 | -22.1 % |
| Q4 | Mar 9, 2026 | $-36.25 | $-12.86 | -181.9 % |
| Q3 | Nov 10, 2025 | $-14.58 | $-15.56 | 6.30 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q3 | Nov 10, 2025 | $0 | $200.00K | -100.0 % |
| Q2 | Aug 14, 2025 | $0 | $200.00K | -100.0 % |
| Q1 | May 6, 2025 | $0 | $500.00K | -100.0 % |
| Q4 | Apr 15, 2025 | $697.00K | $885.00K | -21.2 % |